Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02680795 |
| Title | To Evaluate the Safety and Pharmacokinetics of Belinostat in Patients Who Have Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Spectrum Pharmaceuticals, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| John Wayne Cancer Institute @ Providence Saint John's Health Center | Santa Monica | California | 90404 | United States | Details | |
| The Oncology Institute of Hope and Innovation | Whittier | California | 90603 | United States | Details | |
| Gabrail Cancer Center Research | Canton | Ohio | 44718 | United States | Details |